Role of the Hippo Pathway in Fibrosis and Cancer
AbstractThe Hippo pathway is the key player in various signaling processes, including organ development and maintenance of tissue homeostasis. This pathway comprises a core kinases module and transcriptional activation module, representing a highly conserved mechanism from Drosophila to vertebrates. The central MST1/2-LATS1/2 kinase cascade in this pathway negatively regulates YAP/TAZ transcription co-activators in a phosphorylation-dependent manner. Nuclear YAP/TAZ bind to transcription factors to stimulate gene expression, contributing to the regenerative potential and regulation of cell growth and death. Recent studies have also highlighted the potential role of Hippo pathway dysfunctions in the pathology of several diseases. Here, we review the functional characteristics of the Hippo pathway in organ fibrosis and tumorigenesis, and discuss its potential as new therapeutic targets.
Share & Cite This Article
Kim, C.-L.; Choi, S.-H.; Mo, J.-S. Role of the Hippo Pathway in Fibrosis and Cancer. Cells 2019, 8, 468.
Kim C-L, Choi S-H, Mo J-S. Role of the Hippo Pathway in Fibrosis and Cancer. Cells. 2019; 8(5):468.Chicago/Turabian Style
Kim, Cho-Long; Choi, Sue-Hee; Mo, Jung-Soon. 2019. "Role of the Hippo Pathway in Fibrosis and Cancer." Cells 8, no. 5: 468.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.